Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Differences between blood-pressure-lowering drugs

    The Lancet Date published:

  • PEP trial

    The Lancet Date published:

  • PEP trial

    The Lancet Date published:

  • Combating the new epidemics of chronic diseases and injuries in the Asia-Pacific region

    Medical Journal of Australia Date published:

  • PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.

    Journal of hypertension. Supplement : official journal of the International Society of Hypertension Date published:

  • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

    The Lancet Date published:

  • Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease

    Journal of Cardiac Failure Date published:

  • Blood Pressure and the Risk of Cardiovascular Disease

    New England Journal of Medicine Date published:

  • Blood pressure and stroke risk in Asia Pacific populations

    Date published:

  • A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery

    Acta Orthopaedica Scandinavica Date published:

  • No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients

    Acta Orthopaedica Scandinavica Date published:

  • Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials

    British Medical Journal Date published:

  • Prevention of cardiovascular diseases in developing countries: Agenda for action, statement from a WHO-ISH meeting in Beijing-October, 1999

    CVD Prevention Date published:

  • Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): A randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction

    Journal of Cardiovascular Risk Date published:

  • Reducing the global burden of blood pressure-related cardiovascular disease

    Journal of Hypertension, Supplement Date published:

  • PROGRESS (Perindopril Protection Against Recurrent Stroke Study): Regional characteristics of the study population at baseline

    Journal of Hypertension, Supplement Date published: